Lord, Abbett & Co
MBX icon

Lord, Abbett & Co’s MBX Biosciences MBX Stock Holding History

Lord, Abbett & Co’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$17.4M Buy
+295,987
New +$18.5M 0.05% 322

Other funds holding MBX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Aaron Wealth Advisors
Aaron Wealth Advisors Chicago, Illinois $2.04B AUM 32.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Lord, Abbett & Co's MBX Position: Q3 2026 in Review

Lord, Abbett & Co opened a new position in MBX Biosciences (MBX) in Q3 2026: 295,987 shares worth $17.4M. The stake represents 0.05% of the portfolio and ranks #322 among its holdings.

104 funds tracked by Wall St. Rank hold MBX as of Q3 2026.

  • Lord, Abbett & Co held 295,987 shares of MBX Biosciences worth $17.4M as of Q3 2026.
  • MBX Biosciences was a new Lord, Abbett & Co position in Q3 2026.
  • MBX Biosciences made up 0.05% of Lord, Abbett & Co's portfolio in Q3 2026, its #322 holding.
  • 104 funds tracked by Wall St. Rank held MBX Biosciences as of Q3 2026.

Based on Lord, Abbett & Co's 13F filing for Q3 2026, filed 13 Nov 2026.